A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)

• Status: Completed
• Trial end date: 2002-06-01
• Target enrollment: 0
• Participant gender: All

Summary

A study to evaluate MK0476 and Fluticasone to control asthma in patients with mild persistent asthma.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Fluticasone; Montelukast; Xhance

Criteria

Inclusion Criteria:

• Patient is male or female, 6-14 years of age with mild persistent asthma

• Patient has a history of the following symptoms: wheezing, chest tightness, cough, etc.

• Patient has asthma diagnosed by a doctor

Exclusion Criteria:

• Patient is hospitalized

• Patient has had major surgery or participated in another clinical trial in the last 4 weeks

• Patient has been on a breathing tube for asthma